A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

NCT06069544 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
163
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

BioNTech SE